As of 2025-08-06, the Intrinsic Value of Yunnan Botanee Bio-Technology Group Co Ltd (300957.SZ) is 23.62 CNY. This 300957.SZ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 45.69 CNY, the upside of Yunnan Botanee Bio-Technology Group Co Ltd is -48.30%.
The range of the Intrinsic Value is 18.83 - 32.65 CNY
Based on its market price of 45.69 CNY and our intrinsic valuation, Yunnan Botanee Bio-Technology Group Co Ltd (300957.SZ) is overvalued by 48.30%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 18.83 - 32.65 | 23.62 | -48.3% |
DCF (Growth 10y) | 28.69 - 50.56 | 36.31 | -20.5% |
DCF (EBITDA 5y) | 58.14 - 101.30 | 83.14 | 82.0% |
DCF (EBITDA 10y) | 74.42 - 140.96 | 110.03 | 140.8% |
Fair Value | 8.54 - 8.54 | 8.54 | -81.31% |
P/E | 20.91 - 44.32 | 34.62 | -24.2% |
EV/EBITDA | 14.29 - 33.09 | 25.76 | -43.6% |
EPV | 10.79 - 13.49 | 12.14 | -73.4% |
DDM - Stable | 5.56 - 13.40 | 9.48 | -79.3% |
DDM - Multi | 20.77 - 36.82 | 26.38 | -42.3% |
Market Cap (mil) | 19,354.28 |
Beta | 2.18 |
Outstanding shares (mil) | 423.60 |
Enterprise Value (mil) | 18,633.23 |
Market risk premium | 6.13% |
Cost of Equity | 11.08% |
Cost of Debt | 5.00% |
WACC | 10.74% |